Suppressor of cytokine signaling 3 expression in anaplastic large cell lymphoma. (Q38336235)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15385932%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

Suppressor of cytokine signaling 3 expression in anaplastic large cell lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15385932%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15385932%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

J H Cho-Vega

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15385932%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

G Z Rassidakis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15385932%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

H M Amin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15385932%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

P Tsioli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15385932%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

K Spurgers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15385932%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Y K Remache

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15385932%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

A H Goy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15385932%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

F Gilles

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15385932%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

L Jeffrey Medeiros

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15385932%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

1 November 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15385932%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15385932%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15385932%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15385932%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

1872-1878

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15385932%20AND%20SRC:MED&resulttype=core&format=json

A family of cytokine-inducible inhibitors of signalling

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

SOCS proteins, regulators of intracellular signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

Stat proteins and oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

Functional interaction of STAT3 transcription factor with the cell cycle inhibitor p21WAF1/CIP1/SDI1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

Regulation of Bcl-xL: a little bit of this and a little bit of STAT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

STAT3 activation is required for Asp(816) mutant c-Kit induced tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

Identifying differentially expressed genes in cDNA microarray experiments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

The N-terminal truncated isoform of SOCS3 translated from an alternative initiation AUG codon under stress conditions is stable due to the lack of a major ubiquitination site, Lys-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

Alk+ CD30+ lymphomas: a distinct molecular genetic subtype of non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

Distinct mechanisms of activation of Stat1 and Stat3 by platelet-derived growth factor receptor in a cell-free system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

STAT3 is constitutively activated in Hodgkin cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

Constitutive and specific activation of STAT3 by BCR-ABL in embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

Activation of STAT3 by the c-Fes protein-tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

Expression of v-src in mammary epithelial cells induces transcription via STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

SOCS proteins: negative regulators of cytokine signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

Suppressors of cytokine signalling (SOCS) in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

inferred from DOI database lookup

7 January 2021

based on heuristic

Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

inferred from DOI database lookup

7 January 2021

based on heuristic

Anaplastic lymphoma kinase (ALK) is not expressed in Hodgkin's disease: results with ALK-11 antibody in 327 untreated patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403495

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.LEU.2403495

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15385932%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

2 January 2020

1040441908

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15385932%20AND%20SRC:MED&resulttype=core&format=json